Report: Wegmans extends free atorvastatin offer through end of year
PHILADELPHIA — Wegmans will be offering the popular cholesterol-lowering drug atorvastatin free of charge through the end of the year, according to a report published by the Philadelphia Inquirer Wednesday.
According to the report, the generic equivalent to Lipitor would have sold for $67.88 for 30 tablets and $191.08 for 90 tablets in 2012 if the customer had no insurance to offset the cost. Before facing generic competition in November, 2011, Lipitor was the leading branded prescription as measured in dollars.
"This dovetails with our mission of helping people live better lives through healthy living," Wegmans spokeswoman Jo Natale told the Inquirer.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
NCPA supports Ore. reimbursement, audit, pharmacy choice legislation
NEW YORK — Bills introduced in Oregon’s state legislature would allow employers and other health plan sponsors to have greater knowledge about how pharmacy benefit managers determine the rates at which they pay pharmacies for dispensing generic drugs; establish new standards for pharmacy audits while requiring PBMs to register in the state and be licensed by the state board of pharmacy; and prevent health plans from requiring residents of the state to use mail-order pharmacies.
S.B. 363 would allow Oregonians to fill prescriptions at the pharmacy of their choice, similar to legislation recently enacted in New York and Pennsylvania. Meanwhile, H.B. 2123, in addition to requiring PBMs to register in the state, would include the same maximum allowable cost, or MAC disclosure, and updating requirements featured in S.B. 402.
"No homebuilder would agree to build a house with knowing what they would be paid, the cost of their construction materials or whether they would be held harmless when the cost of lumber or other goods increases," National Community Pharmacists Association second VP and Grants Pass, Ore., pharmacist and pharmacy owner Michele Belcher said. "Yet that’s exactly the situation that community pharmacists are in today. This bill would simply let the pharmacist know how they will be reimbursed for drugs and allows employers to better understand what makes up their drug plan costs."
In one example, at a legislative hearing, a local pharmacist reported being reimbursed less than $1.80 for a prescription for which the previous reimbursement was $8.69. Similar bills are under consideration in the state legislatures of Kentucky, North Dakota and Oklahoma.
PDX, CoverMyMeds partner on prior authorizations
COLUMBUS, Ohio — Pharmacy-automation system maker PDX has made a deal with CoverMyMeds to help pharmacies using PDX’s system to expedite the submission of prior-authorization forms to health insurance plans, PDX said.
The service, which will be offered at no cost to pharmacies, is meant to decrease the administrative hassles of prior authorizations, improve turnaround time and help to stop prescription abandonment.
"It is important that pharmacies have technologies they need to work smarter and faster," PDX CEO Jeff Farris said. "By partnering with CoverMyMeds, PDX customers will have access to another utility that will help streamline the prior authorization rejection process. We remain focused on delivering solutions and services our pharmacy partners require to remain efficient, such as those offered by CoverMyMeds."
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.